Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma

JOURNAL ARTICLE published 14 October 2021 in Current Oncology

Research funded by Ministry of Education, Culture, Sports, Science and Technology (21K07912)

Authors: Yuji Eso | Haruhiko Takeda | Kojiro Taura | Atsushi Takai | Ken Takahashi | Hiroshi Seno